Osteoclastogenic differentiation of macrophages in the development of abdominal aortic aneurysms

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 9, 2016, Pages 1962-1971

  Takei, Yuichiro ^a,b   Tanaka, Teruyoshi ^a   Kent, K Craig ^a   Yamanouchi, Dai ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Aneurysm; Cardiovascular diseases; Metalloproteinases; Osteogenesis; Osteolysis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CALCIUM ION; CALCIUM PHOSPHATE; CATHEPSIN K; CD68 ANTIGEN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEAR FACTOR OF ACTIVATED T CELLS CYTOPLASMIC 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; ZOLEDRONIC ACID; ANGIOTENSIN II; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHLORIDE; MMP9 PROTEIN, MOUSE;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTERY CALCIFICATION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DIFFERENTIATION; CONTROLLED STUDY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; MOUSE MODEL; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ZYMOGRAPHY; ABDOMINAL AORTA; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; C57BL MOUSE; CELL TRANSDIFFERENTIATION; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HUMAN; MALE; METABOLISM; PATHOLOGY; RAW 264.7 CELL LINE; TIME FACTOR;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CALCIUM CHLORIDE; CALCIUM PHOSPHATES; CALCIUM SIGNALING; CELL TRANSDIFFERENTIATION; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; HUMANS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOGENESIS; RAW 264.7 CELLS; TARTRATE-RESISTANT ACID PHOSPHATASE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CALCIFICATION;

EID: 84978033224     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307715     Document Type: Article

References (38)

1. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G, Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010 52 539 548. doi: 10.1016/j.jvs.2010.05.090
2. Kurosawa K, Matsumura JS, Yamanouchi D, Current status of medical treatment for abdominal aortic aneurysm. Circ J 2013 77 2860 2866
3. Takayama T, Yamanouchi D, Aneurysmal disease: The abdominal aorta. Surg Clin North Am 2013 93 877 891, viii. doi: 10.1016/j.suc.2013.05.005
4. Yamanouchi D, Takei Y, Komori K, Balanced mineralization in the arterial system: Possible role of osteoclastogenesis/osteoblastogenesis in abdominal aortic aneurysm and stenotic disease. Circ J 2012 76 2732 2737
5. Liberman M, Pesaro AE, Carmo LS, Serrano CV Jr, Vascular calcification: Pathophysiology and clinical implications. Einstein (Sao Paulo) 2013 11 376 382
6. Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H, Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 2006 12 1410 1416. doi: 10.1038/nm1515
7. Kanazawa K, Kudo A, TRAF2 is essential for TNF-Alpha-induced osteoclastogenesis. J Bone Miner Res 2005 20 840 847. doi: 10.1359/JBMR.041225
8. Kwak HB, Jin HM, Ha H, Kang MJ, Lee SB, Kim HH, Lee ZH, Tumor necrosis factor-Alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1/Cip1). Biochem Biophys Res Commun 2005 330 1080 1086. doi: 10.1016/j.bbrc.2005.03.085
9. Higgins CL, Marvel SA, Morrisett JD, Quantification of calcification in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2005 25 1567 1576. doi: 10.1161/01.ATV.0000172017.79441.73
10. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, Weissleder R, Aikawa E, Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: A role for inflammation. Eur Heart J 2010 31 1975 1984. doi: 10.1093/eurheartj/ehq237
11. Yamanouchi D, Morgan S, Stair C, Seedial S, Lengfeld J, Kent KC, Liu B, Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model. J Vasc Surg 2012 56 455 461. doi: 10.1016/j.jvs.2012.01.038
12. Doherty TM, Uzui H, Fitzpatrick LA, Tripathi PV, Dunstan CR, Asotra K, Rajavashisth TB, Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J 2002 16 577 582
13. Takeshita S, Kaji K, Kudo A, Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 2000 15 1477 1488. doi: 10.1359/jbmr.2000.15.8.1477
14. Maksymov V, Khalifa MA, Bussey A, Carter B, Hogan M, Undifferentiated (anaplastic) carcinoma of the pancreas with osteoclast-like giant cells showing various degree of pancreas duct involvement. A case report and literature review. JOP 2011 12 170 176
15. da Costa CE, Annels NE, Faaij CM, Forsyth RG, Hogendoorn PC, Egeler RM, Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med 2005 201 687 693. doi: 10.1084/jem.20041785
16. Pondel M, Calcitonin and calcitonin receptors: Bone and beyond. Int J Exp Pathol 2000 81 405 422
17. Amarasekara DS, Yu J, Rho J, Bone loss triggered by the cytokine network in inflammatory autoimmune diseases. J Immunol Res 2015 2015 832127. doi: 10.1155/2015/832127
18. Horowitz MC, Xi Y, Wilson K, Kacena MA, Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001 12 9 18
19. Takayanagi H, Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 2009 5 667 676. doi: 10.1038/nrrheum.2009.217
20. Kim J, Sharma RP, Calcium-mediated activation of c-Jun NH2-Terminal kinase (JNK) and apoptosis in response to cadmium in murine macrophages. Toxicol Sci 2004 81 518 527. doi: 10.1093/toxsci/kfh221
21. Halverson PB, Greene A, Cheung HS, Intracellular calcium responses to basic calcium phosphate crystals in fibroblasts. Osteoarthritis Cartilage 1998 6 324 329. doi: 10.1053/joca.1998.0131
22. Lobo FM, Zanjani R, Ho N, Chatila TA, Fuleihan RL, Calcium-dependent activation of TNF family gene expression by Ca2+/calmodulin kinase type IV/Gr and calcineurin. J Immunol 1999 162 2057 2063
23. Addison WN, Azari F, Sørensen ES, Kaartinen MT, McKee MD, Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 2007 282 15872 15883. doi: 10.1074/jbc.M701116200
24. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW, Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000 105 1641 1649. doi: 10.1172/JCI8931
25. Delaissé JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L, Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 2003 61 504 513. doi: 10.1002/jemt.10374
26. Eriksen EF, Díez-Pérez A, Boonen S, Update on long-Term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review. Bone 2014 58 126 135. doi: 10.1016/j.bone.2013.09.023
27. Papapoulos SE, Bone diseases: Bisphosphonates in osteoporosis-beyond 5 years. Nat Rev Rheumatol 2013 9 263 264. doi: 10.1038/nrrheum.2013.57
28. Abe K, Yoshimura Y, Deyama Y, Kikuiri T, Hasegawa T, Tei K, Shinoda H, Suzuki K, Kitagawa Y, Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells. Int J Mol Med 2012 29 1007 1015. doi: 10.3892/ijmm.2012.952
29. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T, Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002 3 889 901
30. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT, Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002 110 625 632. doi: 10.1172/JCI15334
31. Page-McCaw A, Ewald AJ, Werb Z, Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007 8 221 233. doi: 10.1038/nrm2125
32. Rogers TL, Wind N, Hughes R, Nutter F, Brown HK, Vasiliadou I, Ottewell PD, Holen I, Macrophages as potential targets for zoledronic acid outside the skeleton-evidence from in vitro and in vivo models. Cell Oncol (Dordr) 2013 36 505 514. doi: 10.1007/s13402-013-0156-2
33. Tsai SH, Huang PH, Peng YJ, Chang WC, Tsai HY, Leu HB, Chen JW, Lin SJ, Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway. Cardiovasc Res 2013 100 501 510. doi: 10.1093/cvr/cvt230
34. Schindeler A, Little DG, Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro. Biochem Biophys Res Commun 2005 338 710 716. doi: 10.1016/j.bbrc.2005.09.198
35. Nistala H, Lee-Arteaga S, Carta L, Cook JR, Smaldone S, Siciliano G, Rifkin AN, Dietz HC, Rifkin DB, Ramirez F, Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet 2010 19 4790 4798. doi: 10.1093/hmg/ddq409
36. Nakayama A, Morita H, Hayashi N, Nomura Y, Hoshina K, Shigematsu K, Ohtsu H, Miyata T, Komuro I, Inverse correlation between calcium accumulation and the expansion rate of abdominal aortic aneurysms. Circ J 2016 80 332 339. doi: 10.1253/circj.CJ-15-1065
37. Buijs RV, Willems TP, Tio RA, Boersma HH, Tielliu IF, Slart RH, Zeebregts CJ, Calcification as a risk factor for rupture of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2013 46 542 548. doi: 10.1016/j.ejvs.2013.09.006
38. Wang Y, Krishna S, Golledge J, The calcium chloride-induced rodent model of abdominal aortic aneurysm. Atherosclerosis 2013 226 29 39. doi: 10.1016/j.atherosclerosis.2012.09.010